Maryam Jalal

Maryam Jalal joined Ironwood Capital as an Analyst in December 2018. In that role she was responsible for reviewing new investment opportunities, conducting research, performing financial modeling and due diligence, and supporting business development activities and portfolio management. Ironwood Capital, founded in 1997 and headquartered in Avon, Connecticut (with a Boston office), is a junior capital provider to the lower middle market, supplying flexible junior debt and equity to support buyouts, recapitalizations, and growth financings. The firm reports having invested more than $1 billion across 100+ companies.

Jalal earned an undergraduate degree in Accounting and Finance from the Lahore University of Management Sciences (LUMS) in Pakistan and a Master's in Management from Duke University's Fuqua School of Business. Before Ironwood, she worked as a financial analyst at Terakeet, a search-engine-optimization firm, and earlier as a business intelligence analyst at Mobilink GSM, a multinational telecommunications company in Pakistan.

She has since moved on from Ironwood Capital. As of 2026 she is a Senior Associate on the Digital Solutions investments team at UPMC Enterprises, the innovation and commercialization arm of the University of Pittsburgh Medical Center. There she evaluates, structures, and executes strategic investments and partnerships in healthcare technology, assessing the operational and financial feasibility of new ventures and joint partnerships. Note that her Ironwood-era email and phone (above) reflect her former role; her current professional affiliation is UPMC Enterprises.

• As an analyst, Jalal operated within Ironwood Capital's mandate: junior capital ($10–50M checks) for lower-middle-market companies generating $20–250M+ in revenue and $4–25M+ in EBITDA, used for buyouts, recapitalizations, and growth financings.
• Her work centered on the diligence and execution side — financial modeling, research, and due diligence on new opportunities — rather than originating an independent personal thesis.
• In her current role at UPMC Enterprises, her focus is healthcare technology: she backs and partners with companies aligned with UPMC's clinical and innovation mission, emphasizing operational and financial feasibility of early-stage ventures and strategic partnerships.
• Caveat on the stub data: the "Angel Investors / Seed Round" labeling does not match Ironwood Capital's actual profile as a private credit/equity firm for the lower middle market. Treat any "angel/seed" characterization with caution.